Article Text

Download PDFPDF
478 Endometrial cancer in premenopausal women- a nationwide population-based cohort study
  1. Chrysanthos Ioannou1,
  2. Cecilia Malmsten2,
  3. Per Ehn1,
  4. Erik Holmberg3,
  5. Pernilla Dahm Kähler2 and
  6. Karin Stålberg1
  1. 1Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
  2. 2Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden
  3. 3Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Region Västra Götaland, Regional Cancer Center West, Gothenburg, Sweden


Introduction/Background An increased incidence of endometrial cancer (EC) has been noted worldwide, especially in premenopausal women in countries with rapid socioeconomic transition. This study aims to examine tumour and patient’s characteristics and prognosis in premenopausal women with EC by combining validated Swedish registries.

Methodology The study population includes women ≤50 years with EC, included in the Swedish Quality Register Gynaecological Cancer 2010–2021. Register data was manually completed with data from medical records. Cox regression models were used to analyse factors associated with disease-free survival (DFS).

Results The study cohort consisted of 797 women ≤50 years (5%) out of 15902 patients with EC. Only 138 patients (0.9%) were <40 years of age. The majority of patients (n=757, 95%) had endometrioid EC and 40 patients (5%) non-endometrioid EC. The 5-year DFS for the study cohort was 90% (endometrioid 91%, non-endometrioid 65%, FIGO I/II 94%, FIGO III/IV 70% respectively). Women with BMI ≥30 had a higher DFS (94%) compared to women with BMI<30 (87%), p=0.0024. Multivariable analyses showed that factors associated with lower 5-year DFS were non-endometrioid histology, HR (hazard ratio) 3.66 (95% CI 1.81–7.39), FIGO stage III, HR 4.47 (95% CI 2.05 -9.76) and IV, HR 21,17 (95% CI 9.82–45.61). Women with BMI 30–39 had an improved DFS, HR 0.26 (95% CI 0.11–0.65) compared to women with both lower and higher BMI. Use of MHT did not increase the risk of recurrence adjusted HR 0.51 ( 95% CI 0.16–1.67).

Conclusion In this nationwide large cohort study we could demonstrate that, in general, premenopausal women with EC have good prognosis and non-endometrioid EC is rare in this group. Women with obesity (BMI 30–39) had a pronounced decreased risk for recurrence or death than women with lower or higher weight. This may indicate that this group may develop less aggressive EC or that overweight has a protective effect.

Disclosures None.

Abstract 478 Table 1

Uni/multivariable analyses for disease-free survival in women ≤ 50 years with endometrial cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.